
Join to View Full Profile
35 Park StreetSmilow Cancer Hospital at Yale-New HavenNew Haven, CT 06511
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Emory University School of MedicineResidency, Internal Medicine, 2007 - 2010
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2007
Covenant CollegeB.A., 2001
Certifications & Licensure
CT State Medical License 2013 - 2026
GA State Medical License 2009 - 2014
MD State Medical License 2011 - 2014
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations Start of enrollment: 2017 Aug 24
Publications & Presentations
PubMed
- 1 citationsNavigating the winding road toward precision prostate cancer care.Syed Rahman, Adith S Arun, Isaac Yi Kim, William K Oh, Joseph W Kim
Gene. 2026-03-20 - 80 citationsAdjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2025-01-02 - 6 citationsAdaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.Amy E Leader, Timothy R Rebbeck, William K Oh, Alpa V Patel, Eric P Winer
BMC Public Health. 2024-09-18
Books/Book Chapters
Abstracts/Posters
- Single-agent LV305 to induce anti-tumor immune and clinical responses in patients with advanced or metastatic sarcoma and other cancers expressing NY-ESO-1.Neeta Somaiah, Matthew Stephen Block, Joseph W. Kim, Geoffrey Shapiro, Khanh Tu Do, Patrick Hwu, Joseph Paul Eder, Robin Lewis Jones, Sacha Gnjatic, Hailing Lu, Jan Te..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
- Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.Padmanee Sharma, Petri Bono, Joseph W. Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi Narayana Pillai, Patrick Alexander Ott, Filippo G. De Braud, Michael A. Morse, ..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
- CheckMate-032: Phase I/II, open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (...Yelena Yuriy Janjigian, Johanna C. Bendell, Emiliano Calvo, Joseph W. Kim, Paolo Antonio Ascierto, Padmanee Sharma, Patrick Alexander Ott, Petri Bono, Dirk Jaeger, T.R..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
Press Mentions
Joseph Kim, MD, on Liquid Biopsies as a Diagnostic for GI CancersJanuary 28th, 2020
Phase 3 Trial for Inovio's VGX-3100 in Cervical Dysplasia Gets FDA Go-AheadJune 14th, 2017
Grant Support
- Young Investigator Award - 2013ASCOPresent
Professional Memberships
- Member
- Member
- Member
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









